Equity Profile

BLLN

BillionToOne, Inc.

Health CareHealth Care Services$4.6B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

BillionToOne, Inc. operates in the health care sector, focusing on innovative health care services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and will help gauge financial health this quarter.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand and capture market share in the health care sector.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

BLLN Q2-2026 Earnings Preview

Context

Company Snapshot

BillionToOne, Inc. operates in the health care sector, focusing on innovative health care services. The company is significant for its role in advancing personalized medicine and diagnostics, which are increasingly important in modern health care.

Earnings Scorecard·Last 3Q

EPS Beat Streak

EPS Beat Rate

67%

Avg EPS Surprise

+1110.58%

Avg Stock Reaction

+1.25%

Last Quarter Recap

In Q1-2026, BillionToOne reported an EPS of $0.34, significantly exceeding expectations. The stock reacted positively, gaining 1.88% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the strong surprise in the last quarter. However, the lack of analyst estimates adds uncertainty.

Bull Case

If BillionToOne continues its trend of beating EPS estimates, it could signal strong operational performance and growth potential.

Bear Case

Conversely, any signs of revenue stagnation or failure to meet expectations could lead to a negative market reaction.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter?

Given the strong surprise last quarter, the market will closely watch for continued profitability.

How is revenue growth tracking?

Investors need clarity on revenue trends to assess the company's growth trajectory and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating BillionToOne's ability to sustain its recent EPS growth due to its innovative services in personalized medicine.

Supporting Evidence

The last quarter's EPS surprise was exceptionally high, indicating potential for continued strong performance.

Options pricing suggests a significant expected move, which may reflect underlying confidence not captured in consensus estimates.

Key Risk

If the EPS comes in below $0.20, it could invalidate the bullish narrative about the company's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether BillionToOne can sustain its recent performance and continue to grow in a competitive health care landscape.

Bull Confirmed If

An EPS of $0.40 or higher would confirm strong operational performance.

Bear Confirmed If

An EPS below $0.20 would raise concerns about profitability and growth.

Pre-Earnings Positioning

Options Market

Implied Move

±15.08%

Historical Avg

±3.1%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility surrounding the earnings announcement.

Options are pricing ±15.1% while BLLN has averaged ±3.1% over the last 3 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

95.0%

Calls (9K)P/C Ratio: 0.35Puts (2K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If BillionToOne beats expectations, history suggests a potential stock increase of around 1.88%, confirming strong operational health.

In-Line / Cautious

If results are in line with expectations, the stock may see muted reactions as investors await further clarity from management.

Miss

Should the company miss expectations, history indicates a potential decline of around 4.65%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in personalized medicine.
2Management's commentary on revenue growth and market demand.
3Insights into operational efficiencies or cost management strategies.
4Guidance on future earnings expectations and market conditions.
5Responses to competitive pressures in the health care services sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

BillionToOne, Inc. operates in the health care sector, focusing on innovative health care services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and will help gauge financial health this quarter.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand and capture market share in the health care sector.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

BLLN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 3Q

EPS Beat Streak

EPS Beat Rate

67%

Avg EPS Surprise

+1110.58%

Avg Stock Reaction

+1.25%

Last Quarter Recap

In Q1-2026, BillionToOne reported an EPS of $0.34, significantly exceeding expectations. The stock reacted positively, gaining 1.88% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the strong surprise in the last quarter. However, the lack of analyst estimates adds uncertainty.

Bull Case

If BillionToOne continues its trend of beating EPS estimates, it could signal strong operational performance and growth potential.

Bear Case

Conversely, any signs of revenue stagnation or failure to meet expectations could lead to a negative market reaction.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter?

Given the strong surprise last quarter, the market will closely watch for continued profitability.

How is revenue growth tracking?

Investors need clarity on revenue trends to assess the company's growth trajectory and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating BillionToOne's ability to sustain its recent EPS growth due to its innovative services in personalized medicine.

Supporting Evidence

The last quarter's EPS surprise was exceptionally high, indicating potential for continued strong performance.

Options pricing suggests a significant expected move, which may reflect underlying confidence not captured in consensus estimates.

Key Risk

If the EPS comes in below $0.20, it could invalidate the bullish narrative about the company's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether BillionToOne can sustain its recent performance and continue to grow in a competitive health care landscape.

Bull Confirmed If

An EPS of $0.40 or higher would confirm strong operational performance.

Bear Confirmed If

An EPS below $0.20 would raise concerns about profitability and growth.

Pre-Earnings Positioning

Options Market

Implied Move

±15.08%

Historical Avg

±3.1%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility surrounding the earnings announcement.

Options are pricing ±15.1% while BLLN has averaged ±3.1% over the last 3 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

95.0%

Calls (9K)P/C Ratio: 0.35Puts (2K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If BillionToOne beats expectations, history suggests a potential stock increase of around 1.88%, confirming strong operational health.

In-Line / Cautious

If results are in line with expectations, the stock may see muted reactions as investors await further clarity from management.

Miss

Should the company miss expectations, history indicates a potential decline of around 4.65%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in personalized medicine.
2Management's commentary on revenue growth and market demand.
3Insights into operational efficiencies or cost management strategies.
4Guidance on future earnings expectations and market conditions.
5Responses to competitive pressures in the health care services sector.